# FDA recall D-1107-2018

> **Preferred Pharmaceuticals, Inc** · Class II · drug recall initiated 2018-08-15.

## Product

Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807, NDC 68788-6882-9

## Reason for recall

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

## Distribution

Products were distributed to one distributor in Alabama who may have further distributed the product to the consumer level.

## Key facts

- **Recall number:** D-1107-2018
- **Recalling firm:** Preferred Pharmaceuticals, Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-08-15
- **Report date:** 2018-08-29
- **Termination date:** 2019-01-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Anaheim, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1107-2018

## Citation

> AI Analytics. FDA recall D-1107-2018. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-1107-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*